Skip to main content
. 2020 Nov 12;324(22):2292–2300. doi: 10.1001/jama.2020.22760

Figure 2. Time to Clinical Deterioration in the Fluvoxamine and Placebo Groups.

Figure 2.

The median observation time was 15 days (interquartile range, 15-15 days) for the fluvoxamine group and 15 days (interquartile range, 15-15 days) for the placebo group. Study day 0 indicates the day of randomization.